Rituximab EfFicacy IN MyasthEnia Gravis (REFINE)
Clinical trial NCT05868837 · RECRUITING
Trial details
- NCT number
- NCT05868837
- Sponsor
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-02-28
- Primary completion
- 2025-07-31
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.